From clinical trial design through regulatory and reimbursement approval—we put market access intelligence in context.
Overcoming hurdles to market access is no small matter. Increasingly, cost-effectiveness and cost-containment are trumping safety and efficacy.
Forward-thinking biopharma is looking for new ways to anticipate the criteria (we call it “context”), against which their next drug will be evaluated by agencies / payers for reimbursement.
More than tracking health technology assessment (HTA) decisions, pharmaceutical and biotechnology companies need a solution that connects the multiple dimensions of reimbursement, regulatory, and clinical trials. Context Matters built the industry-leading market access intelligence solution linking drug development and market data through a sophisticated model. Flexible and scalable, our solution provides both breadth and depth of timely and accurate data gathered across reimbursement, regulatory, and clinical sources.
Let Context Matters put you in control of your blueprint for market access with the right data and technology.